CytomX Therapeutics, Inc. (CTMX) Insider Trading Activity — Form 4 Filings
Recent CTMX insider trading activity from SEC Form 4 filings, including executive and director buys, sells, awards, filing dates, and data limitations.
Direct answer: CytomX Therapeutics, Inc. (CTMX) has more selling than buying in the recent Form 4 activity available here. The data includes 82 parsed transactions from SEC filings.
SEC data retrieved .
CytomX Therapeutics, Inc. insider activity summary
Recent activity includes 1 open-market buy, 40 sells, and other Form 4 transactions. Buy and sell counts summarize the available recent filings; they are not a complete measure of insider conviction.
Recent Form 4 transactions
| Date | Insider | Type | Reported value |
|---|
| Aug 3, 2026 |
Carvajal Alejandra |
AWARD |
Not disclosed |
| Jun 15, 2026 |
Ogden Christopher |
SELL |
$4,953 |
| Mar 17, 2026 |
Chu Yu-Waye |
SELL |
$136,675 |
| Mar 17, 2026 |
McCarthy Sean A. |
SELL |
$764,138 |
| Mar 17, 2026 |
BELVIN MARCIA |
SELL |
$202,273 |
| Mar 17, 2026 |
Ogden Christopher |
SELL |
$124,112 |
| Feb 2, 2026 |
Lester Rachael |
AWARD |
Not disclosed |
| Feb 2, 2026 |
Chu Yu-Waye |
AWARD |
Not disclosed |
| Feb 2, 2026 |
BELVIN MARCIA |
AWARD |
Not disclosed |
| Feb 2, 2026 |
Ogden Christopher |
AWARD |
Not disclosed |
| Feb 2, 2026 |
McCarthy Sean A. |
AWARD |
Not disclosed |
| Nov 6, 2025 |
McCarthy Sean A. |
SELL |
$461,906 |
Sources and limitations
Source: SEC EDGAR Form 4 filings. Filing data can be delayed, amended, incomplete, or affected by SEC rate limits. Scheduled sales, awards, exercises, and open-market trades have different meanings. This page is informational and is not financial advice.
Frequently asked questions
When was CTMX insider data retrieved?
Sep 17, 2026, 11:10 PM UTC.
Does insider buying guarantee a higher stock price?
No. Insider transactions are one data point and do not predict future returns.
View the full CTMX stock analysis · Search another ticker's Form 4 filings
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.